{"slideshow_credits": null, "snippet": "Bristol-Myers Squibb said the drug had not slowed the progression of advanced lung cancer in a test seeking approval to use it as an initial treatment....", "abstract": "Bristol-Myers Squibb says its best-selling immunotherapy drug Opdivo failed as initial treatment for lung cancer in clinical trial; announcement plunges manufacturer's shares 16 percent and raises value of shares of rival Merck, makers of Keytruda, immunotherapy medication that succeeded in similar clinical trial.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK"}, "web_url": "http://www.nytimes.com/2016/08/06/business/lung-cancer-drug-opdivo-fails-clinical-trial-to-expand-use.html", "lead_paragraph": "Bristol-Myers Squibb said the drug had not slowed the progression of advanced lung cancer in a test seeking approval to use it as an initial treatment.", "headline": {"main": "Immunotherapy Drug Opdivo Fails Clinical Trial to Expand Use", "print_headline": "Immunotherapy Drug Fails Lung Cancer Trial"}, "_id": "57aa084f95d0e021d797ee8d", "word_count": "1045", "multimedia": [{"height": 126, "url": "images/2016/08/06/business/06DRUG/06DRUG-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2016/08/06/business/06DRUG/06DRUG-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 401, "url": "images/2016/08/06/business/06DRUG/06DRUG-articleLarge.jpg", "legacy": {"xlarge": "images/2016/08/06/business/06DRUG/06DRUG-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "401"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2016/08/06/business/06DRUG/06DRUG-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/08/06/business/06DRUG/06DRUG-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2016-08-05T15:59:16+0000", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Clinical Trials", "is_major": "N", "rank": "1"}, {"name": "subject", "value": "Lung Cancer", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "3"}, {"name": "organizations", "value": "Bristol Myers Squibb Company", "is_major": "Y", "rank": "4"}, {"name": "organizations", "value": "Merck & Company Inc", "is_major": "Y", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}